Ozempic

Zentral zugelassenes Arzneimittel · European Medicines Agency · Deutschland

EMA-Produktnummer EMEA/H/C/004174
ATC A10BJ06

Was die Quelle veröffentlicht

Zulassungsinhaber: Novo Nordisk A/S
Administrativer Status: authorised

Dokumente des Herausgebers

Packungsbeilage

Namen, unter denen dieser Datensatz gefunden wird

Vollständige Quelldaten

de:ema:epar:EMEA-H-C-004174

{
  "inn": "semaglutide",
  "name": "Ozempic",
  "holder": "Novo Nordisk A/S",
  "orphan": false,
  "endDate": null,
  "generic": false,
  "smpcUrl": "https://www.ema.europa.eu/de/documents/product-information/ozempic-epar-product-information_de.pdf",
  "species": null,
  "atcCodes": [
    "A10BJ06"
  ],
  "category": "Human",
  "marketed": null,
  "useDomain": "unknown",
  "biosimilar": false,
  "leafletUrl": "https://www.ema.europa.eu/de/documents/product-information/ozempic-epar-product-information_de.pdf",
  "medicineUrl": "https://www.ema.europa.eu/en/medicines/human/EPAR/ozempic",
  "decisionDate": "2026-06-11",
  "sourceStatus": "Authorised",
  "supplyRegime": null,
  "opinionStatus": null,
  "targetSpecies": [],
  "suspensionDate": null,
  "activeSubstance": "semaglutide",
  "advancedTherapy": false,
  "lastUpdatedDate": "2026-08-25",
  "reportTimestamp": "2026-11-08T18:01:45Z",
  "therapeuticArea": "Diabetes Mellitus",
  "emaProductNumber": "EMEA/H/C/004174",
  "authorisationDate": "2018-02-08",
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "de.ema.epar"
  },
  "patientEligibility": "not-assessed",
  "productInformation": {
    "url": "https://www.ema.europa.eu/de/documents/product-information/ozempic-epar-product-information_de.pdf",
    "language": "de",
    "updatedAt": "2026-08-25T12:02:00Z",
    "englishUrl": "https://www.ema.europa.eu/en/documents/product-information/ozempic-epar-product-information_en.pdf"
  },
  "conditionalApproval": false,
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "unknown",
  "exceptionalCircumstances": false,
  "pharmacotherapeuticGroup": "Drugs used in diabetes"
}

Zentral zugelassene Arzneimittel

Source: European Medicines Agency (EMA), EPAR medicines and EPAR documents website data. Product information is linked, not copied.

Abgerufen am: 8. November 2026
Lizenz: Bedingungen des Herausgebers
Quellen-ID: de.ema.epar

Amtliche Quelle

Was diese Quelle nicht belegt

Central authorisations only: every medicine EMA assessed through the centralised procedure, with its status. National, mutual-recognition and decentralised products are not in these reports.
A central authorisation is valid in every EEA country; marketing, availability and reimbursement in a particular country are not established by it, and its prescription classification is not published here, so it stays unknown.
Records join their product-information PDF on the exact EMA product number. Only EMA’s standard “<name>-epar-product-information_<language>.pdf” document counts; where the country’s language has no such PDF the English one is linked. A medicine with no such document, or more than one, has no link.
Therapeutic indications and other clinical text in the reports are not copied.
EMA’s legal notice permits commercial and non-commercial reproduction with acknowledgement of EMA as the source; its exception for third-party content leaves the status of holder-submitted text unconfirmed.
de.ema.article57 also lists centrally authorised medicines (territory "European Union"), by product name, substance, route and holder only. It carries no EMA product number, so its rows are not joined to these records; a consumer that offers both sources sees those medicines twice.

Diesen Datensatz aus Ihrer eigenen Software abrufen

Derselbe Datensatz, mit allen Feldern und seiner Herkunft, ist nur eine Anfrage entfernt. Ein API-Schlüssel ist kostenlos und funktioniert sofort.

Hol dir deinen kostenlosen API-Schlüssel Referenz lesen

GET /v1/drugs/record

curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=de" \
  --data-urlencode "sourceId=de.ema.epar" \
  --data-urlencode "id=de:ema:epar:EMEA-H-C-004174"